which are key biomarkers for Canavan disease due to ASPA gene mutation leading to NAA accumulation in the central nervous system. Despite the small commercial opportunity, with around 1,000 ...
The disease is caused by an inherited mutation of the ASPA gene that codes for aspartoacylase, a protein that breaks down a compound called NAA. Deficiency of aspartoacylase activity results in ...